The triple aim of healthcare is patient satisfaction, quality outcomes, and decreased costs. Navigation is the key to effective care delivery, said Regina Cunningham, PhD, RN, NEA-BC, FAAN, chief executive officer of the Hospital of the University of Pennsylvania, during the Endnote Session at the Oncology Nurse Advisor Navigation Summit.

The cost of cancer has increased substantially over the years and is continuing to trend upward. During a session at the Oncology Nurse Advisor Navigation Summit, Yousuf Zafar, MD, MHS, an associate professor of medicine and public policy at Duke Cancer Institute, gave some facts and figures on cancer costs and how these are impacting patient well-being.

The 2012 American Cancer Society (ACS) guidelines on nutrition and physical activity for cancer survivors suggest achieving and maintaining a healthy weight, engaging in regular physical exercise and following healthy dietary patterns.

During a session at the Oncology Nurse Advisor Navigation Summit, ONS member Pamela J. Haylock, PhD, RN, FAAN, at the Association for Vascular Access in Medina, TX, and Cindy Stern, RN, MSN, CCRP, of the University of Pennsylvania Cancer Network, delivered a joint presentation about some of the hurdles nurse navigators face.

Precision medicine involves the identification of actionable mutations and agents that target those specific pathways. ONS member Debra Wujcik, PhD, RN, FAAN, the director of research at Carevive Systems, Inc., gave an overview of precision medicine therapies at the Oncology Nurse Advisor Navigation Summit.

Palliative care is a patient-centered approach that seeks to optimize quality of life. Advocacy is also important, which includes incorporating patient and family goals into the care plan, promoting communication, actively managing symptoms, promoting and nurturing transcendence and hope, eliminating patients’ and families’ fears of abandonment, and being therapeutically present. At the Oncology Nurse Advisor Navigation Summit, Bonnie Freeman, DNP, RN, ANP, CT, ACHPN, a nurse practitioner in the Department of Supportive Care Medicine at the City of Hope National Medical Center in Duarte, CA, discussed the best strategies related to palliative care.

As many as 25%–30% of all new antineoplastic agents in development are estimated to be oral, and almost half of the 300 medications in phase II and III clinical trials are oral medications. A paradigm shift is taking place in chemotherapy delivery. During a session at the Oncology Nurse Advisor Navigation Summit, ONS member Jan Tipton, MSN, RN, AOCN®, at the University of Toledo Medical Center in Ohio, discussed how cancer is making a shift to oral medications.

Colorectal cancer (CRC) represents 8% of all new cancer cases and 8.4% of all cancer deaths, with a five-year survival rate of 64.9% (between 2007–2013). Pancreatic cancer represents 3.2% of all new cancer cases and 7.2% of all cancer deaths, with a five-year survival rate of just 8.2% (between 2007–2013). ONS member Christine Guarnieri, MSN, RN-BC, OCN®, of Huntington Hospital in New York, discussed both of these cancers at the Oncology Nurse Advisor Navigation Summit.

ONS member Judy B. Koutlas RN, MS, OCN®, manager of oncology navigation at Vidant Medical Center in Greenville, NC, discussed best practices and metrics related to navigation programs to improve nursing performance and patient quality of care during a session at the Oncology Nurse Advisor Navigation Summit.

With the growing demand for cancer services and a shrinking workforce, new ideas and innovative approaches are needed. During a session at the Oncology Nurse Advisor Navigation Summit, ONS member Jean B. Sellers, RN, MSN, administrative clinical director at the University of North Carolina Lineberger Comprehensive Cancer Center in Chapel Hill, discussed the current landscape and future of navigation services.

The estimated cancer prevalence by age in the United States is expected to increase from 216 million in 1975 to 380 million in 2040. With older cancer survivors, the severity of disease and treatment will increase, and the physiologic effects of aging, such as pre-existing conditions and new-onset morbidity, will impact the level of care needed for older adults.

During the keynote address at the Oncology Nurse Advisor Navigation Summit, Brenda Nevidjon, MSN, RN, FAAN, chief executive officer at ONS, addressed the future of oncology care by opening with a quote from Mahatma Gandhi, “The future depends on what you do today.”